Plant-Based Biologics Market By Clinical Trial (Phase I, Phase II, Others); By Source (Tobacco, tobacco cells, tobacco leaves, Nicotiana benthamiana leaves, Carrot cell culture, Rice seeds, Moss, Algae, Duckweed Leafy Biomass, Others); By Product (Taliglucerase alfa, ZMApp, PRX-102, HAI-05, Others); By Diseases (HIV/AIDS, Ebola virus, Cholera, Leprosy, Tuberculosis, Fabry Disease, Anthrax, Pompe Disease, Influenza (Type A, Type B, Type c), Alzheimer, Respiratory Syndromes, Gaucher disease, Cancer, Others); By Mode of Administration (Intramuscular, Oral Administration, Others); By End Users (Hospitals, Clinics, Primary Care Centers, Others);By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2020-2028

Report ID :AMI-791 | Category : Healthcare & IT | Published Date : January, 2021 | Pages : 402 | Format :PDF